Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in 1H 2026 Miv-cel ...

The luxury carmaker channeled its inner superhero with this one. Genesis unveiled the new GV60 Mountain Intervention Vehicle (MIV) this week in Switzerland, an off-road EV that can climb mountains.

After JP Morgan, the company is focusing on getting ready to submit a biologics license application to the FDA for miv-cel in ...

Kyverna Therapeutics’ KYTX lead CAR T-cell therapy candidate, mivocabtagene autoleucel (“miv-cel”, formerly KYV-101), is being developed in a pivotal phase II study for stiff person syndrome (SPS), a ...

The one-off ‘Mountain Intervention Vehicle’ puts some luxury behind rescue operations. The one-off ‘Mountain Intervention Vehicle’ puts some luxury behind rescue operations. is a former news writer ...

Good morning, and welcome to the Kyverna Therapeutics Investor Conference Call. [Operator Instructions] Please note that this call is being recorded. I would now like to introduce Jessica Serra, Head ...

Craig has worked in automotive media for nearly 20 years, producing content for publications ranging from Autoline and AutoGuide to Roadshow by CNET and EV Pulse. Aside from writing, he’s also ...

Advancing valuable commercial opportunity in stiff person syndrome (SPS) following landmark registrational data; Biologics License Application (BLA) submission anticipated in 1H 2026 First patient ...

Days after Genesis showcased a special Genesis GV80 Desert Edition car at the 2025 Dakar Rally, the company has come up with an interesting concept vehicle at the 2025 World Economic Forum annual ...

There is something just so cool about a vehicle on tracks. Whether it be a snowmobile, snow cat, tank or just a sports car or big pickup truck with tracks installed, it's kinda impossible not to be ...